Literature DB >> 32814447

Moving on from 2013 to 2020 European LeukemiaNet recommendations for treating chronic myeloid leukemia: what has changed over the 7 years?

Umut Yilmaz1, Ahmet Emre Eskazan1.   

Abstract

Entities:  

Keywords:  CML; Chronic myeloid leukemia; ELN recommendations; European LeukemiaNet

Mesh:

Substances:

Year:  2020        PMID: 32814447     DOI: 10.1080/17474086.2020.1813564

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


× No keyword cloud information.
  2 in total

Review 1.  Guidelines for the treatment of chronic myeloid leukemia from the NCCN and ELN: differences and similarities.

Authors:  Zehra Narlı Özdemir; Necati Alp Kılıçaslan; Musa Yılmaz; Ahmet Emre Eşkazan
Journal:  Int J Hematol       Date:  2022-09-05       Impact factor: 2.319

2.  Asciminib in chronic myeloid leukemia: many questions still remain to be answered.

Authors:  Ahmet Emre Eşkazan
Journal:  Blood Cancer J       Date:  2021-04-29       Impact factor: 11.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.